Bicara Therapeutics Inc. Common Stock ( BCAX) - Key Metrics
BCAX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.82 | -$0.65 | -$0.65 |
| 2026Q1 | $0 | -$0.93 | -$0.62 | -$0.62 |
| 2025Q4 | $0 | -$0.68 | -$0.43 | -$0.44 |
| 2025Q3 | $0 | -$0.67 | -$0.54 | -$0.54 |
| 2025Q2 | $0 | -$0.50 | -$0.47 | -$0.47 |
BCAX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.05 |
| 2026Q1 | 0% | -5.35 |
| 2025Q4 | 0% | -6.19 |
| 2025Q3 | 0% | -5.89 |
| 2025Q2 | 0% | -4.65 |
BCAX
Price: $24.49
52 week price:
Earnings Per Share: 5.38 USD
P/E Ratio: 3.33
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion